Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - nicotine polacrilex, quantity: 24.44 mg - gum, chewing - excipient ingredients: menthol; sodium carbonate; butylated hydroxytoluene; quinoline yellow aluminium lake; sodium bicarbonate; carnauba wax; purified talc; acesulfame potassium; sorbitol; flavour; colour; calcium carbonate; isobutylene/isoprene copolymer; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; synthetic terpene resin; microcrystalline wax; hydrogenated vegetable oil; mono- and di- glycerides - treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. in smokers currently unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - nicotine polacrilex, quantity: 24.44 mg - gum, chewing - excipient ingredients: quinoline yellow aluminium lake; menthol; sodium carbonate; sodium bicarbonate; sorbitol; purified talc; carnauba wax; acesulfame potassium; butylated hydroxytoluene; flavour; colour; calcium carbonate; isobutylene/isoprene copolymer; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; synthetic terpene resin; microcrystalline wax; hydrogenated vegetable oil; mono- and di- glycerides - treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. in smokers currently unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - nicotine polacrilex, quantity: 24.44 mg - gum, chewing - excipient ingredients: sorbitol; menthol; carnauba wax; sodium carbonate; sodium bicarbonate; quinoline yellow aluminium lake; acesulfame potassium; purified talc; butylated hydroxytoluene; flavour; colour; calcium carbonate; isobutylene/isoprene copolymer; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; synthetic terpene resin; microcrystalline wax; hydrogenated vegetable oil; mono- and di- glycerides - treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. in smokers currently unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - nicotine polacrilex, quantity: 24.44 mg - gum, chewing - excipient ingredients: sorbitol; purified talc; sodium carbonate; acesulfame potassium; butylated hydroxytoluene; menthol; sodium bicarbonate; carnauba wax; quinoline yellow aluminium lake; flavour; colour; calcium carbonate; isobutylene/isoprene copolymer; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; synthetic terpene resin; microcrystalline wax; hydrogenated vegetable oil; mono- and di- glycerides - treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. in smokers currently unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine     excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol light magnesium oxide nitrogen peppermint oil polysorbate 80 purified talc purified water sodium bicarbonate sodium carbonate sucralose titanium dioxide tutti fruitti flavour ql84441 xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 11mg equivalent to 2.2 mg nicotine and incl. overage;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 11mg equivalent to 2.2 mg nicotine and incl. overage     excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax levomenthol light magnesium oxide peppermint oil   purified water sodium bicarbonate sodium carbonate titanium dioxide xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 22mg equivalent to 4.4 mg nicotine and incl. overage;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 22mg equivalent to 4.4 mg nicotine and incl. overage     excipient: acacia acesulfame potassium cafosa 258 soft carnauba wax levomenthol light magnesium oxide peppermint oil   purified water quinoline yellow   sodium carbonate titanium dioxide xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 10mg equivalent to 2 mg nicotine. plus 10% overage;  ;   - chewing gum - 2 mg - active: nicotine polacrilex 10mg equivalent to 2 mg nicotine. plus 10% overage     excipient: acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol magnesium oxide peppermint oil polysorbate 80 sodium bicarbonate sodium carbonate starch sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - nicotine polacrilex 20mg equivalent to 4 mg nicotine. plus 10% overage;  ;   - chewing gum - 4 mg - active: nicotine polacrilex 20mg equivalent to 4 mg nicotine. plus 10% overage     excipient: acesulfame potassium cafosa 258 soft carnauba wax hypromellose levomenthol magnesium oxide peppermint oil polysorbate 80 quinoline yellow sodium carbonate starch sucralose titanium dioxide winterfresh flavour rde4-149 0488110 xylitol   - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus: facilitating smoking cessation in smokers motivated to quit. helping smokers to temporarily abstain from smoking. facilitating smoking reduction in smokers unable or unwilling to quit.

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline consumer healthcare (ireland) limited - nicotine - transdermal patch - 7 milligram(s)/24 hours - drugs used in nicotine dependence; nicotine